G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $148,009 | -89.7% | 64,916 | -80.5% | 0.00% | – |
| Q1 2024 | $1,441,031 | +112.3% | 333,572 | +49.9% | 0.00% | – |
| Q4 2023 | $678,930 | +4435.6% | 222,600 | +2041.4% | 0.00% | – |
| Q3 2023 | $14,969 | -90.0% | 10,395 | -81.5% | 0.00% | – |
| Q1 2023 | $150,187 | -79.1% | 56,040 | -57.6% | 0.00% | – |
| Q4 2022 | $717,434 | -29.6% | 132,124 | +61.9% | 0.00% | – |
| Q3 2022 | $1,019,000 | +786.1% | 81,628 | +251.2% | 0.00% | – |
| Q2 2022 | $115,000 | -84.5% | 23,245 | -76.2% | 0.00% | – |
| Q1 2022 | $741,000 | -19.3% | 97,635 | +8.7% | 0.00% | – |
| Q4 2021 | $918,000 | -55.2% | 89,857 | -41.2% | 0.00% | – |
| Q3 2021 | $2,049,000 | -49.8% | 152,737 | -17.9% | 0.00% | -100.0% |
| Q2 2021 | $4,082,000 | -43.1% | 186,051 | -37.7% | 0.00% | -75.0% |
| Q1 2021 | $7,180,000 | +225.3% | 298,451 | +143.2% | 0.00% | – |
| Q4 2020 | $2,207,000 | +471.8% | 122,695 | +268.2% | 0.00% | – |
| Q3 2020 | $386,000 | +22.5% | 33,326 | +140.7% | 0.00% | -100.0% |
| Q3 2019 | $315,000 | -57.9% | 13,847 | -3.2% | 0.00% | 0.0% |
| Q3 2018 | $748,000 | – | 14,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $16,445,000 | 3.96% |
| Burrage Capital Management LLC | 228,597 | $2,640,000 | 2.08% |
| CHI Advisors LLC | 84,000 | $970,000 | 0.34% |
| Birchview Capital, LP | 80,000 | $924,000 | 0.31% |
| Jackson Creek Investment Advisors LLC | 47,294 | $546,000 | 0.25% |
| Rhenman & Partners Asset Management AB | 190,000 | $2,195,000 | 0.20% |
| AIGEN INVESTMENT MANAGEMENT, LP | 90,985 | $1,051,000 | 0.13% |
| Bellevue Group AG | 721,925 | $8,338,000 | 0.12% |
| PDT Partners, LLC | 139,924 | $1,616,000 | 0.11% |
| Virtus ETF Advisers LLC | 16,713 | $193,000 | 0.10% |